Recent advances on antimony (III/V) compounds with potential activity against tumor cells

SK Hadjikakou, II Ozturk, CN Banti… - Journal of Inorganic …, 2015 - Elsevier
Antimony one of the heavier pnictogens, has been in medical use against microbes and
parasites as well. Antimony-based drugs have been prescribed against leishmaniasis since …

Perspectives of antimony compounds in oncology

P Sharma, D Perez, A Cabrera, N Rosas… - Acta Pharmacologica …, 2008 - nature.com
Antimony, a natural element that has been used as a drug for over more than 100 years, has
remarkable therapeutic efficacy in patients with acute promyelocytic leukemia. This review …

New antimony (III) halide complexes with dithiocarbamate ligands derived from thiuram degradation: The effect of the molecule's close contacts on in vitro cytotoxic …

OS Urgut, II Ozturk, CN Banti, N Kourkoumelis… - Materials Science and …, 2016 - Elsevier
Antimony (III) halide complexes of the formulae {[SbBr (Me 2 DTC) 2] n}(1),{[SbI (Me 2 DTC)
2] n}(2) and {[(Me 2 DTC) 2 Sb (μ 2-I) Sb (Me 2 DTC) 2]+. I 3−}(3)(Me 2 DTC …

Synthesis, characterization and biological activity of antimony (III) or bismuth (III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation

II Ozturk, CN Banti, N Kourkoumelis, MJ Manos… - Polyhedron, 2014 - Elsevier
Antimony (III) or bismuth (III) complexes of formulae {[SbCl (Me 2 DTC) 2] n}(1),{[BiCl (Me 2
DTC) 2] n}(2) and {[Bi (Et 2 DTC) 3] 2}(3)(Me 2 DTCH= dimethyldithiocarbamate, C 3 H 7 NS …

Synthesis, structural characterization and biological study of new organotin (IV), silver (I) and antimony (III) complexes with thioamides

SK Hadjikakou, II Ozturk, MN Xanthopoulou… - Journal of Inorganic …, 2008 - Elsevier
An overview of our work on the synthesis and biological activity of a series of tin (IV), silver (I)
and antimony (III) complexes with thioamides is reported. Organotin (IV) complexes of …

Non steroidal anti-inflammatory drug (NSAIDs) in breast cancer chemotherapy; antimony (V) salicylate a DNA binder

NM Polychronis, CN Banti, CP Raptopoulou… - Inorganica Chimica …, 2019 - Elsevier
The organoantimony (V) derivative of salicylic acid (SalH 2),{[Ph 3 Sb (SalH)] 2 O}(SalOSbi)
was synthesized and tested for its anti-proliferative activity. SalOSbi was characterized by …

Synthesis, characterization and biological studies of new antimony (III) halide complexes with ω-thiocaprolactam

II Ozturk, CN Banti, MJ Manos, AJ Tasiopoulos… - Journal of Inorganic …, 2012 - Elsevier
Three new antimony (III) halide complexes (SbX3, X= Cl, Br and I) with the heterocyclic
thione ω-thiocaprolactam (1-azacycloheptane-2-thione,(Hthcl)) of formulae {[SbCl2 (μ2 …

Novel mixed metal Ag (I)-Sb (III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant …

EI Gkaniatsou, CN Banti, N Kourkoumelis… - Journal of Inorganic …, 2015 - Elsevier
The already known Ag (I)-Sb (III) compound of the formula {Ag (Ph 3 Sb) 3 (NO 3)}(1) and
two novel mixed metal Ag (I)-Sb (III) metallotherapeutics of the formulae {Ag (Ph 3 Sb) 3 …

Triphenylantimony(V) o‐amidophenolates with unsymmetrical N‐aryl group for a reversible dioxygen binding

AI Poddel'sky, YA Kurskii, AV Piskunov… - Applied …, 2011 - Wiley Online Library
New triphenylantimony (V) o‐amidophenolates (AP‐Me, Et) SbPh3 (1) and (AP‐Me, iPr)
SbPh3 (2) with unsymmetrically substituted N‐aryl groups and (AP‐Et, Et) SbPh3 (3) with …

Conjugation of triphenylantimony (V) with carvacrol against human breast cancer cells

M Kapetana, CN Banti, C Papachristodoulou… - JBIC Journal of …, 2022 - Springer
The organoantimony derivative of formula trans-O, O-[Ph3SbV (Carv) 2](TPAC)(CarvH=
carvacrol) is obtained by the oxidation of triphenylstibine (Ph3SbIII) with hydrogen peroxide …